Pristiq Withdrawal & Tapering Guide
desvenlafaxine
Boxed Warning
Suicidality risk in children, adolescents, and young adults under 25 during initial treatment.
In short
Pristiq (desvenlafaxine) is an SNRI with a half-life of 11 hours. Extended-release tablets cannot be split. It is also sold as Khedezla.
- Class
- SNRI
- Half-life
- 11 hours
- Common doses
- 25mg, 50mg, 100mg
Educational reference only. Dose changes are decided with the prescriber who knows your history.
Overview
Desvenlafaxine is the active metabolite of venlafaxine, formulated as an extended-release SNRI for major depressive disorder. It was designed to provide more predictable pharmacokinetics by bypassing CYP2D6 metabolism.
25mg, 50mg, 100mg
Extended-release tablets: 25mg, 50mg, 100mg
Category C (risk cannot be ruled out)
Mechanism of Action
Serotonin-norepinephrine reuptake inhibitor (SNRI). Inhibits both the serotonin and norepinephrine transporters. Unlike its parent compound venlafaxine, it does not require CYP2D6 activation.
Taper Notes
Extended-release tablets cannot be split. Compounding pharmacy needed for doses between available strengths.
Hyperbolic Tapering Guidance
Tablets cannot be crushed/split. Compounding pharmacy essential for fine reductions.
Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.
Common Withdrawal Symptoms
Interactions & Safety
Drug Interactions
- MAOIs — contraindicated (serotonin syndrome risk)
- Serotonergic drugs increase serotonin syndrome risk
- Weak inhibitor of CYP2D6; minor effect on CYP2D6 substrates
Food Interactions
- No significant food effect on pharmacokinetics
- Avoid alcohol during treatment
Contraindications
- MAOIs within 14 days
- Known hypersensitivity to desvenlafaxine or venlafaxine
Toxicity
Serotonin syndrome with serotonergic combinations. Sustained hypertension. Lipid elevations reported. Severe discontinuation syndrome similar to venlafaxine.
Pharmacokinetics
ADME Profile
Bioavailability ~80%. Tmax ~7.5 hours. Food does not significantly affect pharmacokinetics.
~3.4 L/kg
Hepatic conjugation (UGT) and to a minor extent CYP3A4-mediated oxidation. Does not rely on CYP2D6 for activation.
Renal (~45% unchanged, ~24% as glucuronide conjugate). Total urinary recovery ~~70%.
~30%
~215 mL/min (total body clearance)
Need a clinician who understands tapering?
Browse our map of deprescribing-informed providers worldwide.
Related Articles About Pristiq
Can You Cut Pristiq (Desvenlafaxine) in Half? What to Do Instead
No, you cannot cut Pristiq in half. Pristiq (desvenlafaxine) is a 24-hour extended-release tablet, and the FDA label says it must be swallowed whole, never divided, crushed, chewed, or dissolved. Cutting it breaks the slow-release design, so part of the dose can
Sep 27, 2026
Pristiq (Desvenlafaxine) Withdrawal: Why the "One Dose" Design Makes Tapering Hard
Pristiq (desvenlafaxine) withdrawal has a reputation among patients and prescribers for being unusually rough, and the drug's own design is a big part of why. Desvenlafaxine is the active metabolite of venlafaxine, the same compound your liver already converts [Effexor](/drugs/ef
Jul 23, 2026
Other Drug Profiles
The arithmetic of a proportional reduction
The Maudsley Deprescribing Guidelines and NICE NG222 describe reducing SNRI medications by a proportion of the previous dose rather than by a fixed amount, so each cut is smaller than the last. The table shows what that arithmetic produces at 10% per step, using 50 mg only as a worked example. How large each step is, how long it is held, and whether this pattern applies at all are decisions for the person and their prescriber.
| Step | % of starting dose | Worked example (50 mg start) |
|---|---|---|
| Start | 100% | 50 mg |
| Step 1 | 90% | 45 mg |
| Step 2 | 81% | 40.5 mg |
| Step 3 | 73% | 36.5 mg |
| Step 4 | 66% | 32.8 mg |
| Step 5 | 59% | 29.5 mg |
| Step 6 | 53% | 26.6 mg |
| Step 7 | 48% | 23.9 mg |
| Step 8 | 43% | 21.5 mg |
This is an illustration of a published method, not a schedule for anyone. It does not account for how long you have taken Pristiq, your current dose, formulation, or history. TaperCommunity does not recommend doses or dose changes; those are agreed with your prescriber.
Frequently asked questions about Pristiq
What are the withdrawal symptoms of Pristiq (desvenlafaxine)?
Common withdrawal symptoms of Pristiq (desvenlafaxine) include: brain zaps, dizziness, nausea, irritability, headache. Symptom severity varies by individual, dose, and duration of use.
How should I taper off Pristiq (desvenlafaxine)?
Extended-release tablets cannot be split. Compounding pharmacy needed for doses between available strengths. Tablets cannot be crushed/split. Compounding pharmacy essential for fine reductions.
Can I stop Pristiq cold turkey?
Stopping Pristiq abruptly is not recommended. Its half-life is 11 hours, and the receptor adaptations built up during treatment do not reverse at that speed, so a sudden stop tends to produce the sharpest withdrawal. Prescribing guidance favours gradual, proportional reductions agreed with your prescriber.
How long does Pristiq stay in your system?
Pristiq (desvenlafaxine) has a half-life of 11 hours. A drug is mostly cleared after about five half-lives, so Pristiq is largely out of the body about 2 days after the last dose, longer in older adults or with liver or kidney impairment. Withdrawal symptoms often begin before the drug has fully cleared and continue after it has, because the adaptations the brain made during treatment reverse more slowly than the drug leaves the blood.
Recent discussions about Pristiq
What members tapering Pristiq are asking and reporting right now. Personal experience, not medical advice.
- Pristiq Tapering ThreadThis is the forum for everyone tapering Pristiq. When you log a check-in in My Taper, it will appear here. That way you can see how others on the same medication are…Based · 8 months ago
- Feels like my brain capacity is very lowDoes anyone else feel like when they're on antidepressants, their brain capacity is way lower than average? For example, working becomes increasingly difficult because I…Faith · 22 days ago · 8 replies
- Hi I’m SimThis is my 4th attempt to taper from 15 years of Desven. Hyperbolically and super slow this time. 18 months of tapering since June 2024Simplify · 7 months ago · 4 replies
Sources & References
Pristiq (desvenlafaxine) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.
Encyclopedic & chemical databases
Neutral, high-authority entity references.
Peer-reviewed research
Primary literature cited in this taper guide.
- Horowitz MA, Taylor D 2019 — Tapering of SSRI treatment to mitigate withdrawal symptoms (hyperbolic taper) (The Lancet Psychiatry)
- Davies J, Read J 2019 — A systematic review into the incidence, severity and duration of antidepressant withdrawal effects (Addictive Behaviors)
- Framer A 2021 — The patient voice: an exploration of the experience of withdrawal from antidepressants (Therapeutic Advances in Psychopharmacology)
Clinical guidelines
Evidence-based deprescribing and prescribing standards.
Deprescribing-specific resources
Clinician-facing references on tapering protocols.
- Deprescribing.org — Evidence-based deprescribing algorithms from the Bruyère Research Institute
- Royal College of Psychiatrists — Stopping antidepressants — UK clinical guidance on safely discontinuing antidepressants
Patient-advocacy & lived-experience
Long-running communities documenting withdrawal experience.
- Surviving Antidepressants — tapering forum — Long-running community archive of antidepressant taper experiences
- Inner Compass Initiative — Withdrawal Project — Peer-led resources for psychiatric drug withdrawal
- Mad in America — antidepressant withdrawal archive — Journalism and personal narratives on SSRI/SNRI discontinuation
- RxISK — adverse drug reaction reporting — Independent database of patient-reported adverse effects
TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.